Transaction in Own Shares 13 January, 2026 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 13 January, 2026 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 13/01/2026 829,333 27.2950 26.6300 26.9620 LSE GBP 13/01/2026 - - - - Chi-X (CXE) GBP 13/01/2026 - - - - BATS (BXE) GBP 13/01/2026 848,147 31.5600 30.8050 …

Real estate investment trusts (REITs) and the related ETFs didn't set the investing world ablaze last year, even as the Federal Reserve pared interest rates three times. However, that disappointment could give way to better things in 2026.

ReposiTrak, Inc. is a micro-cap SaaS firm focused on supply chain compliance, food safety, and traceability for retailers and suppliers. TRAK's revenue grew 10% YoY, driven by recurring subscriptions and expanding services to existing customers, especially as retailer requirements outpace federal mandates. Operating expenses rose 3%, but revenue outpaced costs, supporting a 28% increase in operating income and strong revenue-per-employee metrics.

The Chinese government this week told some tech companies it would only approve their purchases of Nvidia's H200 AI chips under special circumstances, such as for university research, the Information reported on Tuesday, citing two people with direct knowledge of the situation.

Fidelity National rolls out an industry-first agentic commerce offering, giving banks tools to manage secure AI-led transactions at scale.

PLD and two other REITs stand to gain as the demand for industrial, data center and healthcare assets rises, supported by disciplined capital and low rates.

The S&P 500—tracking 500 of the largest American companies since 1957—reached 6,000 points on Nov. 8, 2024, after surpassing the 5,000-point milestone on Feb. 8 earlier that year. The index crossed the 4,000-point mark in April 2021, just under two years after surpassing 3,000 points in July 2019.

Investors seem jittery about President Trump's support of a measure that would require a lower-cost alternative for credit-card routing.

Apple Inc. (NASDAQ: AAPL) shares are trading relatively flat on Tuesday after the iPhone maker launched Apple Creator Studio, a new subscription bundle designed for creators across Mac, iPad, and iPhone.

Delcath Systems is upgraded from Hold to Buy as sales stabilize and insider confidence grows. DCTH expects to hit the upper end of 2025 guidance at $85M, signaling operational stabilization after earlier guidance cuts. CHOPIN trial results expand HEPZATO's potential beyond liver therapies, supporting a broader market opportunity.

CMTV, BOTJ and SFDL stand out with solid asset bases, strong earnings and credit discipline despite rate headwinds.

Sandisk hits 52-week high as AI infrastructure boom drives demand. BiCS8 technology and expanding hyperscaler partnerships position SNDK for sustained growth ahead.

APLD invests in advanced cooling and dedicated power to ease AI data center constraints as hosting revenues rise and capacity ramps.

BKD's 4Q25 weighted average occupancy rises to 82.5%, capping a year of gains as resident fees climb.

Lower oil prices are expected to cut U.S. drilling activity and reduce output 1% this year from the top producing country, while potentially higher output from Venezuela could add pressure, the Energy Information Administration said on Tuesday.

Artificial intelligence and selective consumer trends are quietly reshaping ETFs in 2026, but not all sectors are moving in lockstep.

JPMorgan Chase & Co. is a Buy, benefiting from lower interest rates and strong net interest income growth. JPM's net interest income reached a record $25 billion, supported by loan growth of 4.1% in Q4 and 11% year-over-year. Loan to deposit ratio rose to 57%, still below industry benchmarks, while external financing declined, easing prior concerns.

Aurora (AUR) is upgraded to Buy with a $5.8 price target, reflecting 22% upside amid early commercialization momentum. AUR has robust $1.25B liquidity, and a narrowing net loss, supporting a 15+ month runway. Key 2026 catalysts include second-generation hardware (50% cost reduction) and the Detmar Logistics contract, validating scalability and technology maturity.

BridgeBio Oncology Therapeutics, Inc. (BBOT) Discusses Clinical Data Updates for BBO-8520, BBO-11818, and BBO-10203 Transcript

Sify Technologies Limited (SIFY) Q3 2026 Earnings Call Transcript